These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34292585)

  • 1. Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.
    MacArthur KM; Baumann BC; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Krausz A; Newman JG; Rajasekaran K; Cannady SB; Brody RM; Karakousis GC; Miura JT; Cohen JV; Amaravadi RK; Mitchell TC; Schuchter LM; Miller CJ
    Cancer; 2021 Oct; 127(19):3591-3598. PubMed ID: 34292585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in sentinel lymph node biopsy utilization in eligible melanoma patients treated with Mohs micrographic surgery or wide local excision: A population-based logistic regression model and survival analysis.
    Knackstedt TJ
    J Am Acad Dermatol; 2023 Apr; 88(4):848-855. PubMed ID: 36368376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and clinical significance of omitting blue dye injection during sentinel lymph node biopsy before Mohs micrographic surgery for malignant melanoma of the lower extremities.
    Kim TH; Kim HJ; Seo JW; Song KH
    Br J Dermatol; 2020 Feb; 182(2):427-433. PubMed ID: 31077333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
    Narang J; Hue JJ; Bingmer K; Hardacre JM; Winter JM; Ocuin LM; Ammori JB; Mangla A; Bordeaux J; Rothermel LD
    J Surg Oncol; 2021 Sep; 124(4):669-678. PubMed ID: 34109633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upstaging of melanoma in situ and lentigo maligna treated with Mohs micrographic surgery rarely results in additional surgical management.
    Levoska MA; Schmults CD; Waldman AH
    Arch Dermatol Res; 2020 Dec; 312(10):753-756. PubMed ID: 32002653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
    Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs surgery.
    Cheraghlou S; Doudican NA; Criscito MC; Stevenson ML; Carucci JA
    J Am Acad Dermatol; 2022 Dec; 87(6):1422-1425. PubMed ID: 35987400
    [No Abstract]   [Full Text] [Related]  

  • 9. Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.
    Aiken TJ; Stahl CC; Schwartz PB; Barrett J; Acher AW; Lemaster D; Leverson G; Weber S; Neuman H; Abbott DE
    J Surg Oncol; 2021 Jan; 123(1):104-109. PubMed ID: 32939750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Cutaneous Melanoma of the Head and Neck With Wide Local Excision Versus Mohs.
    Namin AW; Oudin EM; Tassone PT; Galloway TLI; Dooley LM; Zitsch RP
    Laryngoscope; 2021 Nov; 131(11):2490-2496. PubMed ID: 33844289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies.
    Shah P; Trepanowski N; Grant-Kels JM; LeBoeuf M
    J Am Acad Dermatol; 2024 Sep; 91(3):499-507. PubMed ID: 38768857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
    Monroe MM; Pattisapu P; Myers JN; Kupferman ME
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
    Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
    Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
    Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
    J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.
    Hayek SA; Munoz A; Dove JT; Hunsinger M; Arora T; Wild J; Shabahang M; Blansfield J
    Am Surg; 2018 May; 84(5):672-679. PubMed ID: 29966567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system.
    Vahabzadeh-Hagh AM; Blackwell KE; Abemayor E; St John MA
    Am J Otolaryngol; 2018; 39(5):485-488. PubMed ID: 29803536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of National Comprehensive Cancer Network Guidelines on Case Selection and Outcomes for Sentinel Lymph Node Biopsy in Thin Melanoma.
    Nguyen B; Karia PS; Hills VM; Besaw RJ; Schmults CD
    Dermatol Surg; 2018 Apr; 44(4):493-501. PubMed ID: 29059142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
    Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
    J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.
    Winder AA; Boyer Z; Ch'ng S; Stretch JR; Saw RPM; Shannon KF; Pennington TE; Nieweg OE; Varey AHR; Scolyer RA; Thompson JF; Cust AE; Lo SN; Spillane AJ; Smith AL
    Ann Surg Oncol; 2024 Aug; 31(8):5331-5339. PubMed ID: 38802717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
    Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.